BenzingaJun 12, 3:33 PM ET▼ Negative
Was a clinical-stage dermatology company (Hoth Therapeutics) with no approved products until eleven days before the short report's publication, suggesting a questionable pivot into space.
Rocket One news
$0.4422−4.33%
Close Nov 4, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Rocket One
No recent articles focused on Rocket One.
Also mentions RKTO
Articles that tag RKTO but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology